New Look at Side Effects of Androgen Deprivation Therapy for Prostate Cancer

Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.  A new review of the data suggests that the absolute increases in these risks are fairly low, but proper care is essential to minimize them.

Androgen Blockade for Prostate Cancer May Not Cause Excess Cardiac Deaths

Other adverse effects remain, requiring careful balancing of benefits with risks

Treating prostate cancer patients with drugs that block male hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. But the treatment does increase risks of diabetes and heart disease. How can this outcome hold true?